Epizyme, Inc. 4/A SEC Filings

Filed On	Filing
30 Jun 2020	Form 4/A: Beaulieu Joseph, Corporate Controller Received 700 shares as a grant or award
30 Jun 2020	Form 4/A: Agarwal Shefali, Chief Medical Officer Received 4,000 shares as a grant or award
30 Jun 2020	Form 4/A: Ros Matthew, See Remarks Received 4,000 shares as a grant or award
30 Jun 2020	Form 4/A: Tombesi Paolo, Chief Financial Officer Received 4,000 shares as a grant or award
07 Jan 2020	Form 4/A: Agarwal Shefali, Chief Medical Officer Received 22,577 shares as a grant or award · Granted 34,978 Stock Option (Right to Buy)
11 Sep 2019	Form 4/A: Mott David M, Director Acquired 165,919 shares (Other Transaction)
31 Mar 2016	Form 4/A: Ho Peter Tai-Ching, Chief Development Officer Bought 2,000 shares ($33K)
05 Sep 2014	Form 4/A: Goldfischer Carl, Director Holds 2,829,396 shares of Common Stock, par value $0.0001 per share
05 Sep 2014	Form 4/A: Bay City Capital Llc, 10% owner and 3 others Holds 2,829,396 shares of Common Stock, par value $0.0001 per share
28 Aug 2014	Form 4/A: Goldfischer Carl, Director Holds 3,025,396 shares of Common Stock, par value $0.0001 per share
28 Aug 2014	Form 4/A: Bay City Capital Llc, 10% owner and 3 others Holds 3,025,396 shares of Common Stock, par value $0.0001 per share

Comments